Latest Accounting News

Alvo Minerals has updated its entitlement offer to include free attaching options, aiming to raise $1.56 million to fund exploration and working capital. The offer targets eligible shareholders with a $0.02 share price and options exercisable at $0.05 over three years.

National Australia Bank has updated key details on its 2025 interim dividend, including dividend reinvestment and bonus security plans, setting clear terms for shareholders ahead of the July payment.

M3 Mining Limited has announced significant board changes following shareholder requisitions withdrawal, appointing new directors and initiating a strategic review focused on operational discipline and shareholder value.

ANZ Group Holdings Limited has updated its interim dividend details, confirming an 83-cent payout per share, partially franked at 70%, payable on July 1, 2025. The bank also outlined its Dividend Reinvestment and Bonus Security Plans with shares priced at AUD 28.89.

Chilwa Minerals Limited has reported strong assay results from its Mpyupyu Dune deposit in Malawi, reinforcing the potential for a significant upgrade to its mineral resource estimates. Improved assay turnaround times are accelerating progress across multiple deposits.

Vection Technologies has landed a $1 million contract to enhance cyber and data protection for national security intelligence, extending its footprint in the defence sector. This deal builds on previous engagements and signals potential for further growth.

Castile Resources has successfully detected Iron Ore, Copper, and Gold mineralisation at Pathfinder 38 using innovative Ambient Noise Tomography Survey technology, marking a first in exploration targeting. This breakthrough could redefine the company’s strategy to expand its Rover 1 style deposits.

Papyrus Australia reported a $52,000 operating cash outflow for April 2025 but bolstered its liquidity with $239,000 in financing inflows, extending its funding runway to over a year.

Aspermont Limited reports steady subscription growth with $11.2 million in annual recurring revenue despite a dip in total revenue, while gearing up for new data product launches and an IPO.

Chorus Limited’s 2024 fibre regulatory report reveals a stable $5.9 billion asset base and revenue close to the maximum allowed, with a $153.5 million wash-up balance carried forward.

Pacific Edge Limited has launched a NZ$20 million capital raise to bolster its cash reserves amid the loss of Medicare coverage for its bladder cancer diagnostic tests, aiming to accelerate US market adoption and support new product development.

Pacific Edge Limited reported a resilient FY25 performance despite losing Medicare coverage for its Cxbladder tests in the US, announcing a $20 million equity raise to support commercialization and growth.